Antipsychotics-To Respond or Not to Respond?

Slideshow

A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
DBS

DBS: A Solution to Treatment-Resistant Schizophrenia

May 14th 2024
Article
Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021
Podcast
Gone in a puff of smoke? Researchers investigated the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis and co-occurring CUD.

Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder

May 10th 2024
Article
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021
Podcast
Here are highlights from the fourth day of this year’s APA Annual Meeting.

The 2024 APA Annual Meeting: Tuesday, May 7

May 8th 2024
Article
The extension trial aims to address the cognitive impairment often observed in schizophrenia.

Investigators Share Baseline Data From Study on Iclepertin for Schizophrenia at APA Annual Meeting

May 7th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.